Body and Mind Inc. Share Price Other OTC
Equities
BMMJ
US09689V1008
Pharmaceuticals
Sales 2022 | 31.64M 2.64B | Sales 2023 | 22.82M 1.9B | Capitalization | 11.88M 991M |
---|---|---|---|---|---|
Net income 2022 | -28M -2.34B | Net income 2023 | -20M -1.67B | EV / Sales 2022 | 0.73 x |
Net Debt 2022 | 11.67M 974M | Net Debt 2023 | 18.38M 1.53B | EV / Sales 2023 | 1.33 x |
P/E ratio 2022 |
-0.39
x | P/E ratio 2023 |
-0.52
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 86.53% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Mills
CEO | Chief Executive Officer | 55 | 12/18/12 |
Dong Shim
DFI | Director of Finance/CFO | 40 | 15/16/15 |
Chief Operating Officer | 59 | 15/18/15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Joshua Rosen
BRD | Director/Board Member | 51 | 01/23/01 |
Brent Reuter
BRD | Director/Board Member | 56 | 16/19/16 |
Michael Mills
CEO | Chief Executive Officer | 55 | 12/18/12 |
1st Jan change | Capi. | |
---|---|---|
+39.33% | 6.11B | |
-18.38% | 4.35B | |
-9.17% | 3.19B | |
+3.98% | 3.15B | |
-3.41% | 2.51B | |
+48.74% | 1.98B | |
-4.82% | 1.74B | |
-1.24% | 1.63B | |
-8.96% | 1.6B |